Maintain Flexibility in your Workflow without Compromising Quality – Cryopreserved Leukopaks
September 15, 2020Alameda, CA – September 15, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today the addition of Cryopreserved Leukopaks […]
AllCells Announces Expanded Product Portfolio, Guaranteed Cell-Count Leukopaks
August 17, 2020Alameda, CA – August 13, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today that it has expanded its […]
Chimeric Antigen Receptor (CAR) T-Cell Therapy
July 20, 2020Re-tasking our body’s own immune system to treat cancer has been a major scientific goal over the last few decades. According to the National Cancer Institute, it is estimated that […]
Mobilized Peripheral Blood: Maximize Your CD34+ Yield
July 8, 2020Hematopoietic stem and progenitor cells (HSPCs) are primarily found in the bone marrow, which is the main site of hematopoiesis in humans. The CD34 marker is most commonly associated with […]
Engineered T-Cells: A look at Autologous and Allogeneic CAR-T Cell Immunotherapies
June 12, 2020Re-tasking our body’s own immune system to treat cancer has been a major scientific goal over the last few decades. According to the National Cancer Institute, it is estimated that […]
Product Update Notification – Leukopaks Shipping at 2-8°C
May 21, 2020Dear Valued Customer, As part of our commitment to quality, we are continuously improving our processes, products, and logistics. To this end, we wanted to notify our Leukopak customers of […]
Cryopreserved PBMCs Offer Advantages Over Fresh
May 6, 2020Peripheral Blood Mononuclear Cells (PBMCs) derived from Leukopaks are a rich source of leukocytes, the ideal starting material for isolating T cells, B cells, natural killer cells, and monocytes. Many […]
AllCells is Considered an Essential Business – Delivering at Partial Capacity
April 8, 2020Dear Valued Client, Providing our customers with high quality materials to produce the next generation of cell and gene therapies while providing world-class partnership and support is at the heart […]
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
February 7, 2019February 7, 2019 Walkersville, MD (USA) / Basel (CH) – Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range […]
AllCells Announces New Faster Delivery Times
May 15, 2018May 15, 2018 ALAMEDA, Calif.–(BUSINESS WIRE)–AllCells, LLC, the leading supplier of blood-derived cells and services for immuno- and cell therapy development, announced today that it has changed its business model […]
